UBS Starts Biohaven Pharmaceutical Holding (BHVN) at Buy, 'Diversified innovative pipeline with multiple upside drivers'
Tweet Send to a Friend
(Updated - February 6, 2024 4:39 AM EST)
UBS analyst Ashwani Verma initiates coverage on Biohaven Pharmaceutical Holding (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma initiates coverage on Biohaven Pharmaceutical Holding (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
